Rybelsus (semaglutide)

pCPA File Number: 21518
Negotiation Status:
Under consideration for negotiation
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CADTH Project Number:
SR0637-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable